FDA Warns Industry: We’re Looking ‘Closely And More In-Depth At Class II Recalls’
Also: Troubles with production and process controls at the heart of most class II’s, agency analysis reveals
The US FDA says it’s keeping a sharp eye on medical device manufacturers that initiate the moderate-risk recalls – especially firms that trigger multiple class II’s in a given year.
You may also be interested in...
The recalled vents are designed to provide high-flow therapy to patients, but problems can crop up “if the system pressure reaches the default maximum limit,” the US agency says. The recall is more bad news for Philips, which recently initiated a separate class I recall of certain breathing and ventilator devices.
The US agency on 3 August said the webform should be used by manufacturers to report shortages of products deemed critical to fighting the ongoing COVID-19 pandemic.
Alere Medical and its now-defunct subsidiary Arriva Medical will pay the US government $160m to settle allegations that they violated the False Claims Act. It’s the second settlement that Alere has entered into with the Department of Justice in recent weeks.